A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.
作者信息
Champault G, Patel J C, Bonnard A M
出版信息
Br J Clin Pharmacol. 1984 Sep;18(3):461-2. doi: 10.1111/j.1365-2125.1984.tb02491.x.
Abstract
摘要
相似文献
1
A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.一种美洲锯棕榈植物提取物治疗良性前列腺增生的双盲试验。
Br J Clin Pharmacol. 1984 Sep;18(3):461-2. doi: 10.1111/j.1365-2125.1984.tb02491.x.
2
3
[Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo].[用锯叶棕提取物治疗前列腺腺瘤引起的梗阻症状。与安慰剂对比的双盲临床研究]
Minerva Urol Nefrol. 1985 Jan-Mar;37(1):87-91.
4
[Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study].[锯叶棕果实提取物治疗良性前列腺增生。一项安慰剂对照双盲研究的结果]
MMW Fortschr Med. 1999 Jun 24;141(25):62.
5
Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.锯叶棕与良性前列腺增生：不比安慰剂更有效。
Prescrire Int. 2010 Aug;19(108):181-2.
6
15 years' survey of safety and efficacy of Serenoa repens extract in benign prostatic hyperplasia patients with risk of progression.对患有病情进展风险的良性前列腺增生患者使用锯叶棕果实提取物安全性和有效性的15年调查
Urologia. 2019 Feb;86(1):17-22. doi: 10.1177/0391560318772466. Epub 2018 May 9.
7
Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia.
Arch Esp Urol. 1995 Jan-Feb;48(1):97-103.
8
Serenoa repens for benign prostatic hyperplasia.用于良性前列腺增生的锯叶棕。
Cochrane Database Syst Rev. 2002(3):CD001423. doi: 10.1002/14651858.CD001423.
9
The value of permixon in benign prostatic hypertrophy.舍尼通治疗良性前列腺增生的价值。
Br J Urol. 1986 Feb;58(1):36-40. doi: 10.1111/j.1464-410x.1986.tb05424.x.
10
Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.锯叶棕（保前列）。其治疗良性前列腺增生的药理学及疗效综述。
Drugs Aging. 1996 Nov;9(5):379-95. doi: 10.2165/00002512-199609050-00008.
引用本文的文献
1
for the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement: An Updated Cochrane Review.用于治疗良性前列腺增生所致下尿路症状：Cochrane系统评价更新版
World J Mens Health. 2024 Jul;42(3):518-530. doi: 10.5534/wjmh.230222. Epub 2024 Jan 2.
2
Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement.锯叶棕提取物治疗前列腺良性增生所致的下尿路症状。
Cochrane Database Syst Rev. 2023 Jun 22;6(6):CD001423. doi: 10.1002/14651858.CD001423.pub4.
3
for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis.用于治疗良性前列腺增生引起的下尿路症状：系统评价和荟萃分析。
Investig Clin Urol. 2021 Sep;62(5):520-534. doi: 10.4111/icu.20210254.
4
Use of saw palmetto () extract for benign prostatic hyperplasia.使用锯叶棕提取物治疗良性前列腺增生。
Food Sci Biotechnol. 2019 Apr 17;28(6):1599-1606. doi: 10.1007/s10068-019-00605-9. eCollection 2019 Dec.
5
A substitute variety for agronomically and medicinally important Serenoa repens (saw palmetto).一个在农艺学和药用方面重要的 Serenoa repens（锯棕榈）的替代品种。
Sci Rep. 2019 Mar 18;9(1):4709. doi: 10.1038/s41598-019-41150-z.
6
Hypothesis on (Bartram) small extract inhibition of prostatic 5-reductase through an approach on 5-reductase x-ray structure.关于（巴特拉姆）小提取物通过对5-还原酶X射线结构的研究方法抑制前列腺5-还原酶的假说。
PeerJ. 2016 Nov 22;4:e2698. doi: 10.7717/peerj.2698. eCollection 2016.
7
Randomized double-blind controlled clinical trials with herbal preparations of Serenoa repens fruits in treatment of lower urinary tract symptoms : An overview.使用锯叶棕果实草药制剂治疗下尿路症状的随机双盲对照临床试验：一项综述。
Wien Med Wochenschr. 2017 May;167(7-8):177-182. doi: 10.1007/s10354-016-0526-2. Epub 2016 Nov 29.
8
Serenoa repens for benign prostatic hyperplasia.用于良性前列腺增生的锯叶棕。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD001423. doi: 10.1002/14651858.CD001423.pub3.
9
Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.锯叶棕单药治疗良性前列腺增生症（BPH）：一项更新的 Cochrane 系统评价。
BJU Int. 2012 Jun;109(12):1756-61. doi: 10.1111/j.1464-410X.2012.11172.x. Epub 2012 May 2.
10
Serenoa repens (saw palmetto): a systematic review of adverse events.锯叶棕（Serenoa repens）：不良事件的系统评价
Drug Saf. 2009;32(8):637-47. doi: 10.2165/00002018-200932080-00003.
本文引用的文献
1
Inhibition of androgen metabolism and binding by a liposterolic extract of "Serenoa repens B" in human foreskin fibroblasts.“锯叶棕B”脂甾醇提取物对人包皮成纤维细胞雄激素代谢及结合的抑制作用
J Steroid Biochem. 1984 Jan;20(1):515-9. doi: 10.1016/0022-4731(84)90264-4.
2
The possible mechanism of protection induced by dexamethasone against sudden death due to coronary ligation in conscious rats.地塞米松对清醒大鼠冠状动脉结扎所致猝死的保护作用可能机制。
Br J Pharmacol. 1983 Jun;79(2):327-9. doi: 10.1111/j.1476-5381.1983.tb11003.x.
3
Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.前列腺良性增生的一种新疗法——Permixon与大鼠前列腺胞质雄激素受体的结合。
J Steroid Biochem. 1984 Jan;20(1):521-3. doi: 10.1016/0022-4731(84)90265-6.
4
The pathogenesis of benign prostatic hyperplasia.
Am J Med. 1980 May;68(5):745-56. doi: 10.1016/0002-9343(80)90267-3.
5
Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.前列腺肥大中的双氢睾酮。I. 人前列腺增生组织中双氢睾酮的形成及含量
J Clin Invest. 1970 Sep;49(9):1737-45. doi: 10.1172/JCI106391.
6
Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues.从出生到老年的人类前列腺内源性类固醇水平：正常组织与病变组织的比较。
J Endocrinol. 1978 Jul;78(1):7-19. doi: 10.1677/joe.0.0780007.
Zotero 插件